NANDROVA P
Fast-acting Nandrolone Phenylpropionate 100 mg/ml injection for muscle recovery, nitrogen retention, and rehabilitation.
CAS Number: 62-90-8
Nandrolone Phenylpropionate is indicated for promoting muscle recovery, improving strength, supporting nitrogen retention, red blood cell production, and lean muscle regeneration. It is commonly used in clinical or therapeutic settings requiring fast-acting anabolic support.
NANDROVA P by Nova Techsciences is presented as an injectable formulation containing Nandrolone Phenylpropionate at 100 mg/ml. Nandrolone Phenylpropionate is an esterified nandrolone compound identified by CAS Number 62-90-8. It is chemically different from Nandrolone Decanoate and should be treated as a separate pharmaceutical substance with its own composition, quality documentation, contraindications and regulatory status.
This information is intended to provide clear product identification and responsible safety guidance. It does not replace an authorised Summary of Product Characteristics, prescribing information, patient leaflet or consultation with a qualified healthcare professional.
Product Information
Important NANDROVA P details include:
- Product name: NANDROVA P
- Active compound: Nandrolone Phenylpropionate
- Strength: 100 mg/ml
- Dosage form: Injectable formulation
- CAS Number: 62-90-8
- Brand: Nova Techsciences
The product label should clearly state the full ingredient composition, excipients, administration route, batch number, manufacturing date, expiry date and approved storage conditions. Website information should remain consistent with the vial, outer packaging, catalogue and Certificate of Analysis.
Quality Control and Traceability
Injectable formulations require controlled production and documented laboratory assessment. Quality records may include raw-material identification, active-compound assay, impurity analysis, sterility testing, microbiological controls, particulate examination and container-closure integrity.
Every NANDROVA P batch should have a unique identification number linked to its production and testing records. Statements relating to purity, manufacturing quality or compliance should only be published when supported by current, verifiable documentation.
For the United Kingdom, Netherlands and other European markets, the page should clearly disclose the applicable marketing-authorisation status, legal supply category, responsible manufacturer and adverse-event reporting procedure.
Important Safety Information
Nandrolone is an anabolic-androgenic steroid. It may produce serious adverse effects and should only be considered under qualified medical supervision where its use is legally authorised. Potential concerns associated with nandrolone include hormonal suppression, fertility changes, cardiovascular effects, altered cholesterol levels, liver or kidney complications and signs of virilisation.
NANDROVA P must not be presented for self-medication, unsupervised physique enhancement or use by minors. Dosing schedules, injection techniques, cycles and compound combinations should not be taken from unofficial internet sources.
Related Nova Techsciences Products
ROXONOVA
ROXONOVA is listed as an injectable formulation containing Stanozolol 50 mg/ml, with CAS Number 10418-03-8. It is a separate anabolic-androgenic compound requiring its own quality records, liver-related safety warnings, contraindications and regulatory assessment.
TRENOVA E
TRENOVA E is presented as a Trenbolone Enanthate 200 mg/ml injectable. Its page previously displayed CAS Number 10161-34-9, which identifies Trenbolone Acetate; the TRENOVA E product record has been corrected to CAS Number 1629618-98-9.
NANDROVA D
NANDROVA D contains Nandrolone Decanoate 250 mg/ml, with CAS Number 360-70-3. Its decanoate ester distinguishes it chemically from NANDROVA P, so the two products should not be treated as interchangeable.
TESTOVA P
TESTOVA P is presented as Testosterone Propionate 100 mg/ml, identified by CAS Number 57-85-2. Its product information should emphasise verified composition, contraindications, professional supervision, batch testing and applicable pharmaceutical regulation.
NANDROVA P should ultimately be presented through accurate compound identification, transparent quality documentation, clear regulatory status and balanced safety communication.
Important Information & FAQs
Precautions & Contraindications
Precautions
- Use only under strict medical supervision.
- Monitor liver, kidney, and hormone levels.
- Use sterile IM injection techniques.
- Avoid alcohol and unapproved medications.
- Discontinue and seek medical help if unusual symptoms occur.
Contraindications
- Do not use if allergic to Nandrolone Phenylpropionate or anabolic steroids.
- Avoid in pregnant or breastfeeding women.
- Not suitable for patients with severe liver, kidney, or cardiac disease.
- Contraindicated in individuals with prostate or breast cancer.
- Avoid in uncontrolled hypertension.
Related Products
BOLDENOVA
Boldenone Undecylenate 250 mg/ml injection for lean bulking, endurance, and performance enhancement.
DROSTANOVA P
Dry, anti-estrogenic Drostanolone Propionate 100 mg/ml injectable for cutting, muscle hardening, and strength enhancement.
NANDROVA D
Nandrolone Decanoate 250 mg/ml injection for lean bulking, recovery, and joint support.
NOVA CUT MIX
High-potency cutting blend injection (Testosterone, Trenbolone, Drostanolone) for fat loss, muscle hardness, and strength enhancement.